AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

The Cholesterol Lowering Drug Market in Germany, 2019 to 2024 - Drivers, Restraints, Opportunities, Political, Socio-Economic, and Technological Factors - ResearchAndMarkets.com

May 22, 2019

DUBLIN--(BUSINESS WIRE)--May 22, 2019--

The “Germany Cholesterol Lowering Drug Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2024” report has been added to ResearchAndMarkets.com’s offering.

The country research report on Germany cholesterol lowering drug market is a customer intelligence and competitive study of the Germany market. Moreover, the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the Germany market. Also, factors that are driving and restraining the cholesterol lowering drug market are highlighted in the study.

This is an in-depth business intelligence report based on qualitative and quantitative parameters of the market. Additionally, this report provides readers with market insights and detailed analysis of market segments to possible micro levels. The companies and dealers/distributors profiled in the report include manufacturers & suppliers of cholesterol lowering drug market in Germany.

Segmentation based on Class of Drugs

The report provides detailed insights into:

1. Demand and supply conditions of cholesterol lowering drug market

2. Factor affecting the cholesterol lowering drug market in the short run and the long run

3. The dynamics including drivers, restraints, opportunities, political, socio-economic factors, and technological factors

4. Key trends and future prospects

5. Leading companies operating in cholesterol lowering drug market and their competitive position in Germany

6. The dealers/distributors profiles provide basic information of top 10 dealers & distributors operating in (Germany) cholesterol lowering drug market

7. Matrix: to position the product types

8. Market estimates up to 2024

The report answers questions such as:

1. What is the market size of cholesterol lowering drug market in Germany?

2. What are the factors that affect the growth in cholesterol lowering drug market over the forecast period?

3. What is the competitive position in Germany cholesterol lowering drug market?

4. What are the opportunities in Germany cholesterol lowering drug market?

5. What are the modes of entering Germany cholesterol lowering drug market?

Key Topics Covered

1. Report Overview

1.1. Report Description

1.2. Research Methods

1.3. Research Approaches

2. Executive Summary

3. Market Overview

3.1. Introduction

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

3.2.4. Challenges

3.3. PEST-Analysis

3.4. Porter’s Diamond Model for Germany Cholesterol Lowering Drug Market

3.5. Growth Matrix Analysis

3.6. Competitive Landscape in Germany Cholesterol Lowering Drug Market

4. Germany Cholesterol Lowering Drug Market by Class of Drugs

4.1. Statins

4.2. Fixed-dose Combinations

4.3. Cholesterol Absorption Inhibitors

4.4. Ion Exchange Resins

4.5. Fibrates

4.6. PCSK9 Inhibitors

4.7. Novel Cholesterol-lowering Drugs

5. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/ks1cw4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190522005555/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Cardiovascular Drugs

KEYWORD: EUROPE GERMANY

INDUSTRY KEYWORD: HEALTH CARDIOLOGY PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 05/22/2019 10:43 AM/DISC: 05/22/2019 10:43 AM

http://www.businesswire.com/news/home/20190522005555/en